Voluntis on receiving the CE Mark for Oleena

This is the 13th regulatory clearance worldwide obtained by Voluntis strengthening its name as a pioneer turned leader in digital therapeutics. Oleena‘s new version embeds new clinical algorithms that provide decision support recommendations to patients. Through Oleena, Voluntis introduces a smarter daily companion for people with cancer that also aims to help care teams by simplifying treatment management.

Oleena a mobile application to be used by cancer patients for the monitoring of their disease and management of their symptoms.

Link to their press release